Literature DB >> 20082204

[Identification and grouping of pain patients according to claims data].

A Freytag1, G Schiffhorst, R Thoma, K Strick, C Gries, A Becker, R-D Treede, G Müller-Schwefe, H-R Casser, C Luley, A Höer, M Ujeyl, H Gothe, J Kugler, G Glaeske, B Häussler.   

Abstract

The ICD classification does not provide the opportunity to adequately identify pain patients. Therefore we developed an alternative method for the identification and classification of pain patients which is based on prescription and diagnoses data from the year 2006 of one nationwide sickness fund (DAK) and which is led by two main assumptions: 1. Beneficiaries without prescription of an analgetic drug but with a diagnosis pattern that is characteristic of patients who are treated with opioids are also likely to be pain patients. 2. Each combination of diagnosis groups can be traced back to one primary diagnosis out of a diagnosis group according to the patient classification system CCS (Clinical Classifications Software). The selection of this diagnosis group (CCS) allows for the allocation of the beneficiary to only one pain type. As a result we identified 65 combinations of CCS diagnosis groups--aggregated to nine "CCS pain types"--to which 77.1% of all patients with at least two opioid prescriptions can be allocated: 26.3% to pain due to arthrosis, 18.0% to pain due to intervertebral disc illnesses, 13.1% to other specific back pain, 6.7% to neuropathic pain, 4.5% to unspecific back pain, 4.2% to headache, 2.4% to pain after traumatic fractures, 1.3% to pain of multimorbid, high-maintenance patients, and 0.6% to cancer pain. Based on our method beneficiaries who have a high probability of suffering from moderate to strong pain can be identified and included in further claims data analyses of health care delivery and utilization pattern of pain-related disorders in Germany.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20082204     DOI: 10.1007/s00482-009-0861-y

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  5 in total

1.  Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment.

Authors:  Harald Breivik; Beverly Collett; Vittorio Ventafridda; Rob Cohen; Derek Gallacher
Journal:  Eur J Pain       Date:  2005-08-10       Impact factor: 3.931

2.  [New pain diagnosis in the German version of the ICD-10].

Authors:  W Rief; R-D Treede; U Schweiger; P Henningsen; H Rüddel; P Nilges
Journal:  Nervenarzt       Date:  2009-03       Impact factor: 1.214

3.  Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS).

Authors:  Christoph Maier; Jan Hildebrandt; Regine Klinger; Christine Henrich-Eberl; Gabriele Lindena
Journal:  Pain       Date:  2002-06       Impact factor: 6.961

4.  [Pain treatment facilities in Germany. Ambulatory, day care and inpatient facilities for patients with chronic pain].

Authors:  G Lindena; J Hildebrandt; H C Diener; P Schöps; C Maier
Journal:  Schmerz       Date:  2004-02       Impact factor: 1.107

5.  [Risk assessment in pain therapy].

Authors:  D Schoeffel; H R Casser; M Bach; H G Kress; R Likar; H Locher; W Steinleitner; M Strohmeier; H Brunner; R D Treede; W Zieglgänsberger; J Sandkühler
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

  5 in total
  7 in total

1.  [The new code F45.41].

Authors:  H Lucius; R-D Treede
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

2.  [Opioid therapy in patients with back pain. Claims data analysis for patient group characterization, influence on opioid therapy and work disability].

Authors:  A Höer; A Freytag; G Schiffhorst; S Schellhammer; M Thiede; G Glaeske; B Häussler
Journal:  Schmerz       Date:  2011-04       Impact factor: 1.107

3.  The Risk of Ischemic Cardio- and Cerebrovascular Events Associated with Oxycodone-Naloxone and Other Extended-Release High-Potency Opioids: A Nested Case-Control Study.

Authors:  Kathrin Jobski; Bianca Kollhorst; Edeltraut Garbe; Tania Schink
Journal:  Drug Saf       Date:  2017-06       Impact factor: 5.606

4.  [Coming to light. The problem of identification and grouping of pain patients].

Authors:  B Arnold
Journal:  Schmerz       Date:  2010-02       Impact factor: 1.107

5.  Feasibility and long-term efficacy of a proactive health program in the treatment of chronic back pain: a randomized controlled trial.

Authors:  A Hüppe; C Zeuner; S Karstens; M Hochheim; M Wunderlich; H Raspe
Journal:  BMC Health Serv Res       Date:  2019-10-21       Impact factor: 2.655

6.  Pain And The Use Of Gabapentinoids In German Nursing Home Residents - Results From An Analysis Based On Statutory Health Insurance Data.

Authors:  C Bantel; F Hoffmann; K Jobski
Journal:  J Pain Res       Date:  2019-11-22       Impact factor: 3.133

7.  Diagnoses indicating pain and analgesic drug prescription in patients with dementia: a comparison to age- and sex-matched controls.

Authors:  Falk Hoffmann; Hendrik van den Bussche; Birgitt Wiese; Gerd Glaeske; Hanna Kaduszkiewicz
Journal:  BMC Geriatr       Date:  2014-02-12       Impact factor: 3.921

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.